
Ardian finances Sagard’s acquisition of Ipackchem
Ardian has provided unitranche debt in support of Sagard's buyout of Ipackchem, a French producer of packaging products, from Céréa Capital.
It marks the 100th transaction completed by the Ardian Private Debt subsidiary.
The debt facility provided by Ardian is primarily intended to finance Ipackchem's future add-on acquisitions.
Upon Céréa's investment in 2014, the company generated revenues of €60m. According to an Ardian release, the company's revenues remain unchanged.
Since Céréa led the company’s spinout from Chesapeake in 2014, the group has expanded into South Africa through the acquisition of a local business, and more recently in Brazil where it opened a greenfield facility.
Sagard's acquisition of Ipackchem gives its management team, which remains invested in the group, the resources to pursue further international development through both organic growth and acquisitions of new groups and manufacturing plants, the GP said in a statement.
Previous funding
In January 2014, Céréa backed the carve-out of what was then Spec Chem Packaging from the British business Chesapeake. Chesapeake itself had recently been sold by backers Oaktree Capital and Irving Place Capital in a separate deal to the Carlye Group.
According to unquote" data, the deal saw Céréa take a majority stake in the group for a value estimated between €25-50m.
Company
Founded in 1987 by Jean-Philippe Morvan as part of the Air Products group, Ipackchem is a manufacturer of rigid plastic packaging products intended for the specialty chemicals industries and for products such as flavours, fragrances and agrochemicals.
The group is active in three continents and manages five production sites in France, the UK, Hungary, South Africa and Brazil. Ipackchem currently employs around 350 people and reports sales of €60m.
People
Sagard – Antoine Ernoult-Dairaine, Saïk Paugam (partners). Ipackchem – Jean-Philippe Morvan (CEO).
Ardian – Guillaume Chinardet (head private debt France).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater